论文部分内容阅读
1983年以来,我们在动物实验的基础上将山东省工业陶瓷研究设计院研制的羟基磷灰石生物陶瓷(HAC)用于临床,现报告如下。 1.临床资料:14例患者均行颗粒状、块状、长条状羟基磷灰石植入。其中男11例,女3例,年龄12～60岁,平均33.4岁。下颌骨造釉细胞瘤3例,颌骨囊肿4例,外伤所致颌骨齿槽嵴缺损1例,牙龈癌术后下颌骨部分缺损3例,第一、二鳃弓综合征下颌骨升枝一侧先天缺损1例。
Since 1983, we have applied the hydroxyapatite bioceramic (HAC) developed by Shandong Institute of Industrial Ceramics to the clinical research based on animal experiments. The report is as follows. 1. Clinical data: All 14 patients underwent granular, massive, strip hydroxyapatite implantation. Including 11 males and 3 females, aged 12 to 60 years, an average of 33.4 years of age. 3 cases of mandibular ameloblastoma, 4 cases of jaw cyst, 1 case of mandibular alveolar ridge defect caused by trauma, 3 cases of partial mandibular defect of gingival cancer, 3 cases of mandibular ligation of the first and second branchial arch syndrome One side of the birth defect in 1 case.